» Articles » PMID: 23301078

Expansion of Activated Memory CD4+ T Cells Affects Infectivity of CCR5-tropic HIV-1 in Humanized NOD/SCID/JAK3null Mice

Overview
Journal PLoS One
Date 2013 Jan 10
PMID 23301078
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Humanized mice reconstituted with human hematopoietic cells have been developed as an experimental animal model for human immunodeficiency virus type 1 (HIV-1) infection. Myeloablative irradiation is usually performed to augment the engraftment of donor hematopoietic stem cells (HSCs) in recipient mice; however, some mouse strains are susceptible to irradiation, making longitudinal analysis difficult. We previously attempted to construct humanized NOD/SCID/JAK3(null) (hNOJ) mice, which were not irradiated prior to human HSC transplantation. We found that, over time, many of the reconstituted CD4(+) T cells expanded with an activated effector memory phenotype. Therefore, the present study used hNOJ mice that were irradiated (hNOJ (IR+)) or not (hNOJ (IR-)) prior to human HSC transplantation to examine whether the development and cellularity of the reconstituted CD4(+) T cells were influenced by the degree of chimerism, and whether they affected HIV-1 infectivity. Indeed, hNOJ (IR+) mice showed a greater degree of chimerism than hNOJ (IR-) mice. However, the conversion of CD4(+) T cells to an activated effector memory phenotype, with a high percentage of cells showing Ki-67 expression, occurred in both hNOJ (IR+) and hNOJ (IR-) mice, probably as a result of lymphopenia-induced homeostatic expansion. Furthermore, when hNOJ (IR+) and hNOJ (IR-) mice, which were selected as naïve- and memory CD4(+) T cell subset-rich groups, respectively, were infected with CCR5-tropic HIV-1 in vivo, virus replication (as assessed by the plasma viral load) was delayed; however, the titer subsequently reached a 1-log higher level in memory-rich hNOJ (IR-) mice than in naïve-rich hNOJ (IR+) mice, indicating that virus infectivity in hNOJ mice was affected by the different status of the reconstituted CD4(+) T cells. Therefore, the hNOJ mouse model should be used selectively, i.e., according to the specific experimental objectives, to gain an appropriate understanding of HIV-1 infection/pathogenesis.

Citing Articles

SARS-CoV-2 and HIV: Impact on Pulmonary Epithelial Cells.

Evans N, Schneider A, Castro-Piedras I, Oliver A, Mabry A, Garcia A Life (Basel). 2022; 12(9).

PMID: 36143354 PMC: 9500782. DOI: 10.3390/life12091317.


Mice with humanized immune system as novel models to study HIV-associated pulmonary hypertension.

Rodriguez-Irizarry V, Schneider A, Ahle D, Smith J, Suarez-Martinez E, Salazar E Front Immunol. 2022; 13:936164.

PMID: 35990658 PMC: 9390008. DOI: 10.3389/fimmu.2022.936164.


Perspectives on Non-BLT Humanized Mouse Models for Studying HIV Pathogenesis and Therapy.

Terahara K, Iwabuchi R, Tsunetsugu-Yokota Y Viruses. 2021; 13(5).

PMID: 33924786 PMC: 8145733. DOI: 10.3390/v13050776.


Development of an Inflammatory CD14 Dendritic Cell Subset in Humanized Mice.

Iwabuchi R, Ide K, Terahara K, Wagatsuma R, Iwaki R, Matsunaga H Front Immunol. 2021; 12:643040.

PMID: 33790912 PMC: 8005643. DOI: 10.3389/fimmu.2021.643040.


Introduction of Human Flt3-L and GM-CSF into Humanized Mice Enhances the Reconstitution and Maturation of Myeloid Dendritic Cells and the Development of Foxp3CD4 T Cells.

Iwabuchi R, Ikeno S, Kobayashi-Ishihara M, Takeyama H, Ato M, Tsunetsugu-Yokota Y Front Immunol. 2018; 9:1042.

PMID: 29892279 PMC: 5985304. DOI: 10.3389/fimmu.2018.01042.


References
1.
David S, Smith M, Lopez G, Adany I, Mukherjee S, Buch S . Selective transmission of R5-tropic HIV type 1 from dendritic cells to resting CD4+ T cells. AIDS Res Hum Retroviruses. 2001; 17(1):59-68. DOI: 10.1089/088922201750056799. View

2.
Nie C, Sato K, Misawa N, Kitayama H, Fujino H, Hiramatsu H . Selective infection of CD4+ effector memory T lymphocytes leads to preferential depletion of memory T lymphocytes in R5 HIV-1-infected humanized NOD/SCID/IL-2Rgammanull mice. Virology. 2009; 394(1):64-72. DOI: 10.1016/j.virol.2009.08.011. View

3.
Manz M . Human-hemato-lymphoid-system mice: opportunities and challenges. Immunity. 2007; 26(5):537-41. DOI: 10.1016/j.immuni.2007.05.001. View

4.
Shultz L, Ishikawa F, Greiner D . Humanized mice in translational biomedical research. Nat Rev Immunol. 2007; 7(2):118-30. DOI: 10.1038/nri2017. View

5.
Legrand N, Weijer K, Spits H . Experimental models to study development and function of the human immune system in vivo. J Immunol. 2006; 176(4):2053-8. DOI: 10.4049/jimmunol.176.4.2053. View